AI-Native Scoping Reviews & Evidence Mapping

Built on 810 linked references, this review maps the evidence on Ebola virus disease — from vaccines and monoclonal antibodies to relapse, viral persistence, survivor sequelae, diagnostics, outbreak control, and hidden system failures — making the full read valuable for anyone who wants the whole Ebola evidence landscape in one place.

Central venous catheter infection prevention is not a single-product story: this review shows that sustained CLABSI/CRBSI reduction depends on maintenance bundles, chlorhexidine-based care, closed-access systems, daily line-necessity review, staff competency, and audit feedback working together. Built from 326 original studies and 608,263 participant/sample observations, the full read maps where infection rates fall by 42% to over 90%, where risk persists despite bundles, and which maintenance strategies are most clinically actionable across adult, pediatric, neonatal, oncology, and hemodialysis populations.

This review maps a large clinical evidence base showing that COVID-19 vaccines were generally linked to a strong safety-benefit balance: serious complications such as myocarditis and VITT were rare, while protection against severe COVID-19 outcomes and death remained substantial. Read the full paper to see which risks were truly recurrent, which populations were most vulnerable, and how the balance differed by vaccine platform, age, pregnancy, chronic disease, and immunocompromised status.

Therapeutic drug monitoring of antibiotics turns dosing from guesswork into measurable precision, especially in critically ill, pediatric, burn, ECMO, renal-replacement, and other high-risk patients where standard regimens often miss PK/PD targets. This SAIMSARA evidence map is worth reading because it separates practical dosing signals from implementation noise, mapping β-lactams, vancomycin, aminoglycosides, toxicity thresholds, assay reliability, digital dosing tools, and stewardship workflows across 394 original studies.

Hantavirus infection is not just a rare rodent-borne fever: this evidence map shows it as a multisystem vascular infection driven by ecology, endothelial dysfunction, thrombocytopenia, and renal or cardiopulmonary injury. The full SAIMSARA paper and machine-readable JSON provide structured, reference-linked evidence across 1,084 original studies, covering diagnosis, exposure risk, Andes-virus transmission, severity markers, One Health surveillance, and the still-unproven therapeutic frontier.